IL3 and infection: As a result of this observation, we expanded our investigation to include other transforming mutations and determine if: 1) acquired mutations also arose in other transgenes, 2) whether the mutations were present prior to IL-3 withdrawal, 3) if they were enriched in weakly transforming oncogenes, and 4) if the time in culture following infection impacted the transformation rate.